Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 4-6 October 2016
The Committee adopted by consensus positive opinions for initial marketing authorisationapplications for:
HALAGON (halofuginone), from Emdoka BVBA, a generic antiparasitic product for the reduction and prevention of diarrhoea due to infection with Cryptosporidiium parvum in newborn calves; and
Cepedex (dexmedetomidine), from CP-Pharma Handelsgesellschaft mbH, a generic psycholeptic product for sedation and analgesia in dogs and cats.
Click on this link for more information.